Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Wood

Showing results (31-40 of 666) with videos related to

Pageof 67
Sort By:
The Lancet. Infectious Diseases|October 1, 2011
Time to get serious about HIV antiretroviral resistanceEvan Wood, Julio S G Montaner
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2007
When to initiate HIV antiretroviral therapy: do benefits other than survival deserve greater attention?Evan Wood, Julio S G Montaner
Addiction Science & Clinical Practice|March 25, 2025
Rethinking trazodone for insomnia in alcohol use disorderJeffrey Pan, Jürgen Rehm, Evan Wood
Addiction (Abingdon, England)|October 10, 2020
Commentary on Jin et al. (2020): Expanding the impact of opioid agonist therapy for opioid use disorder-are there lessons from the HIV/AIDS response?Jan Klimas, Evan Wood, Rita McCracken
Harm Reduction Journal|March 18, 2006
Initiation of opiate addiction in a Canadian prison: a case reportEvan Wood, Ronald Lim, Thomas Kerr
Addiction (Abingdon, England)|November 5, 2016
How can we investigate the role of topiramate in the treatment of cocaine use disorder more thoroughly?Jan Klimas, Evan Wood, Daniel Werb
Addiction Science & Clinical Practice|December 10, 2016
Alcohol use in opioid agonist treatmentSeonaid Nolan, Jan Klimas, Evan Wood
Drug and Alcohol Review|June 23, 2015
Pharmacotherapy for alcohol addiction in a patient with alcoholic cirrhosis and massive upper gastrointestinal bleed: A case studySamantha Young, Evan Wood, Keith Ahamad
Lancet (London, England)|August 5, 2008
Supervised injecting facilities: time for scale-up?Thomas Kerr, Julio Montaner, Evan Wood
The International Journal on Drug Policy|April 13, 2010
Cannabis policy: time to move beyond the psychosis debateDaniel Werb, Benedikt Fischer, Evan Wood
Pageof 67

Showing results (31-40 of 666) with videos related to

Sort By:
Pageof 67
The Lancet. Infectious Diseases|October 1, 2011
Time to get serious about HIV antiretroviral resistanceEvan Wood, Julio S G Montaner
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2007
When to initiate HIV antiretroviral therapy: do benefits other than survival deserve greater attention?Evan Wood, Julio S G Montaner
Addiction Science & Clinical Practice|March 25, 2025
Rethinking trazodone for insomnia in alcohol use disorderJeffrey Pan, Jürgen Rehm, Evan Wood
Addiction (Abingdon, England)|October 10, 2020
Commentary on Jin et al. (2020): Expanding the impact of opioid agonist therapy for opioid use disorder-are there lessons from the HIV/AIDS response?Jan Klimas, Evan Wood, Rita McCracken
Harm Reduction Journal|March 18, 2006
Initiation of opiate addiction in a Canadian prison: a case reportEvan Wood, Ronald Lim, Thomas Kerr
Addiction (Abingdon, England)|November 5, 2016
How can we investigate the role of topiramate in the treatment of cocaine use disorder more thoroughly?Jan Klimas, Evan Wood, Daniel Werb
Addiction Science & Clinical Practice|December 10, 2016
Alcohol use in opioid agonist treatmentSeonaid Nolan, Jan Klimas, Evan Wood
Drug and Alcohol Review|June 23, 2015
Pharmacotherapy for alcohol addiction in a patient with alcoholic cirrhosis and massive upper gastrointestinal bleed: A case studySamantha Young, Evan Wood, Keith Ahamad
Lancet (London, England)|August 5, 2008
Supervised injecting facilities: time for scale-up?Thomas Kerr, Julio Montaner, Evan Wood
The International Journal on Drug Policy|April 13, 2010
Cannabis policy: time to move beyond the psychosis debateDaniel Werb, Benedikt Fischer, Evan Wood
Pageof 67